Health Care · In Vitro & In Vivo Diagnostic Substances · Nasdaq · CIK 811641 · FYE Dec 31 · Prices AT CLOSE 2026-08-28 (USD) Last $9.94 · Day −0.80% · Mkt cap $90M · 1Y +62.4% · Off 52W high −17.9% · Vol (1Y) 52.6% Price2023-08-28 → 2026-08-28 ICCC close: $4.5 on 2023-08-28 to $9.9 on 2026-08-28. Split-adj closes · 240 of 5,314 · price returnⓘ At a glance | Short interest0.2% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)+1.14% | | Top-10 13F concentration81.4% | | Next report (est.)2026-11-12 |
SI 2026-08-14 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$30.7M | | Earnings (TTM)$787,373 | | ROE−3.8% | | Net margin−3.8% | | ROIC3.9% | | Debt / equity0.34× | | Total debt / EBITDA2.05× | | Sales growth 3Y14.2% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+61.6% | | 1Y+62.4% | | 3Y+119.4% | | 5Y+10.0% | | 10Y+38.4% | | Since incept. (ann.)+4.3% |
Total return · from 2005-07-11ⓘ Risk | Ann. volatility (1Y)52.6% | | Ann. volatility (3Y)53.2% | | Sharpe (1Y)1.21 | | Sharpe (3Y)0.76 | | Max drawdown (1Y)−32.9% | | Max drawdown (3Y)−40.0% | | Beta (3Y vs SPY)0.66 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 260,327 | $2M | 2.88% | new | | MORGAN STANLEY | 221,716 | $1M | 2.45% | +77.8% | | RENAISSANCE TECHNOLOGIES LLC | 151,789 | $960,824 | 1.68% | +0.7% | | Cresset Asset Management, LLC | 135,267 | $856,240 | 1.50% | +0.0% | | Bleichroeder LP | 101,594 | $643,090 | 1.12% | +0.0% | | GEODE CAPITAL MANAGEMENT, LLC | 65,765 | $416,393 | 0.73% | −9.0% | | DIMENSIONAL FUND ADVISORS LP | 56,030 | $354,669 | 0.62% | +3.2% | | Steadtrust LLC | 54,370 | $344,162 | 0.60% | −4.2% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-13 | $0.20 | +233.3% | $7.2M | +11.5% | | 2026-03-31 | 2026-05-14 | $0.21 | +31.3% | $10.4M | +28.4% | | 2025-12-31 | 2026-03-04 | −$0.32 | −455.6% | $7.6M | −1.6% | | 2025-09-30 | 2025-11-13 | −$0.02 | — | $5.5M | −8.4% |
As-reported XBRL · next 2026-11-12 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
